PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How is Crohn's disease distinguished?

ANSWER

A variety of diagnostic procedures and lab tests are used to distinguish Crohn's disease from other inflammatory gastrointestinal conditions like ulcerative colitis.

From: Crohn’s Disease Overview WebMD Medical Reference

SOURCES: 

Crohn's & Colitis Foundation of America. "Crohn's Diagnosis & Testing."

FDA. “FDA approves Inflectra, a biosimilar to Remicade.” “FDA approves Amjevita, a biosimilar to Humira.”

National Digestive Diseases Information Clearinghouse.

Uptodate.com. "Overview of the medical management of severe or refractory Crohn disease in adults."

 

Reviewed by Minesh Khatri on June 21, 2018

SOURCES: 

Crohn's & Colitis Foundation of America. "Crohn's Diagnosis & Testing."

FDA. “FDA approves Inflectra, a biosimilar to Remicade.” “FDA approves Amjevita, a biosimilar to Humira.”

National Digestive Diseases Information Clearinghouse.

Uptodate.com. "Overview of the medical management of severe or refractory Crohn disease in adults."

 

Reviewed by Minesh Khatri on June 21, 2018

NEXT QUESTION:

How is Crohn's disease diagnosed?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.